Table 1. Demographic and clinicopathological characteristics of patients (n=57).
| Characteristics | Values | |
|---|---|---|
| Age (yr), median | 42 (23–69) | |
| Gravida, median | 2 (0–6) | |
| Parity, median | 2 (0–4) | |
| Tumor size (cm), median | 6 (1–26) | |
| Serum CA-125 (U/mL), median | 21 (4–65) | |
| >35 | 10 (17.5%) | |
| <35 | 28 (49.1%) | |
| Unknown | 19 (33.3%) | |
| Smoking habit | ||
| Yes | 14 (24.6%) | |
| No | 39 (68.4%) | |
| Unknown | 4 (7%) | |
| Surgical type | ||
| TAH | 11 (19.3%) | |
| TAH+BSO | 14 (24.6%) | |
| TAH+USO | 4 (7%) | |
| VH | 1 (1.8%) | |
| Abdominal myomectomy | 26 (45.6%) | |
| Hysteroscopic myomectomy | 1 (1.8%) | |
| Uterine localization | ||
| Intramural | 38 (66.7%) | |
| Subserous | 12 (21.1%) | |
| Submucous | 7 (12.3%) | |
| Mitosis | ||
| 0–5 | 19 (33.3%) | |
| 5–10 | 32 (56.1%) | |
| ≥10 | 6 (10.5%) | |
| Cellularity | ||
| Moderate | 11 (19.3%) | |
| High | 46 (80.7%) | |
| Necrosis | ||
| Absent | 48 (84.2%) | |
| Multifocal | 9 (15.8%) | |
| Atypia | ||
| Mild | 14 (24.6%) | |
| Mild to moderate | 23 (40.4%) | |
| Moderate | 9 (15.8%) | |
| Moderate to severe | 11 (19.3%) | |
| Recurrence rate | 8 (14%) | |
| After hysterectomy | 2 (3.5%) | |
| After myomectomy | 6 (10.5%) | |
| Recurrent pathology | ||
| STUMP | 7 (12.3%) | |
| LMS | 1 (1.8%) | |
| Median follow-up (mo), (min-max) | 57 (16–125) | |
LMS, leiomyosarcoma; STUMP, uterine smooth muscle tumors of uncertain malignant potential; TAH+BSO, Total abdominal hysterectomy+bilateral salpingo-oophorectomy; TAH+USO, total abdominal hysterectomy+unilateral salpingo-oophorectomy; TAH, total abdominal hysterectomy; VH, vaginal hysterectomy.